Connect with us

Health

African Health Scientists Attend Monkeypox Virus Workshop

Published

on

Monkeypox virus workshop

By Kestér Kenn Klomegâh

With rising cases of Monkeypox virus in Africa, the Centre for Disease Control (Africa CDC) and the African Society for Laboratory Medicine (ASLM) have jointly held their first training on Real-Time PCR-based Monkeypox virus (MPXV) testing for 20 African Union Member States in Abuja, Nigeria.

It was the first in the series of hands-on training on real-time PCR-based monkeypox virus (MPXV) diagnosis launched and organized in partnership with the Nigeria Centre for Disease Control (NCDC) in June.

The three-day training workshop is designed to cover a combination of theoretical and hands-on training in the collection and handling of MPXV suspected specimens; isolation of nucleic acid; detection of MPXV using RT-PCR assay; interpretation and reporting of results for public health interventions.

Furthermore, the Africa CDC in partnership with Jiangsu Bioperfectus Technologies Co., Ltd. will distribute MPXV RT-PCR kits to expand testing in participating Member States.

Dr Yenew Kebede, Head Division of Laboratory Systems and Networks at the Africa CDC, said: “Laboratory testing capacity is key to expanding MPXV surveillance in endemic and non-endemic countries across the continent. This training is timely and critical to building and expanding MPXV testing capacity and capability across the continent. We will continue to organize additional trainings and distribute testing kits to the additional African Member States in order to strengthen MPXV surveillance in the continent.”

Dr Ifedayo Adetifa, Director General of NCDC, commented: “Establishing diagnostic capacity for infectious diseases including for monkeypox virus is an essential first step in gaining the understanding required for preparedness and response. So, we are very delighted to partner with Africa CDC to conduct hands-on training for 20 African countries on the RT-PCR-based detection of the monkeypox virus. The training covers a range of topics from collection and handling of the specimen to RT-PCR testing and reporting of results to inform response and containment strategies.”

Dr Ahmed Ogwell, Acting Director of the Africa CDC, said: “Africa CDC will continue to support the Member States in strengthening their capacity and capability to detect and respond to disease outbreaks. Recently, we have issued a call for more support to the Member States and increased access to diagnostics, therapeutics and vaccines to limit the spread of MPXV. The MPXV training and the distribution of test kits are key to expanding MPXV surveillance across the continent.”

The participants are expected to put into practice the skills and knowledge gained from this training to expand MPXV testing and surveillance in their home country. Furthermore, the training workshop will create a network of laboratory experts to collaborate and share expertise and resources in MPXV detection and response.

The training was coordinated and supported through the Africa CDC – Africa Pathogen Genomics Initiative (Africa PGI). The training workshop targeted 20 participants from 20 African Union (AU) Member States: Benin, Chad, Cote d’Ivoire, Democratic Republic of Congo, Ethiopia, Gabon, Ghana, Guinéa, Liberia, Mali, Mozambique, Niger, Republic of Congo, Senegal, Sierra Leone, South Sudan, Sudan, Togo, Uganda, and Zambia.

3 Comments

3 Comments

  1. Pingback: African Health Scientists Attend Monkeypox Virus Workshop - Cdb.io

  2. Pingback: African Health Scientists Attend Monkeypox Virus Workshop - Buy Cbd Oil 11

  3. Pingback: African Health Scientists Attend Monkeypox Virus Workshop – Business Post Nigeria

Leave a Reply

Health

WHO, Edo Intensify Response to Combat Monkeypox

Published

on

Monkeypox virus

By Adedapo Adesanya

The World Health Organisation (WHO) and the Edo State government have intensified a coordinated response to contain the spread of the Monkeypox disease.

So far, Nigeria has reported 357 suspected cases with 133 confirmed monkeypox cases from 25 states – Lagos, Adamawa, Delta, Rivers, Edo, Bayelsa, Nasarawa Plateau FCT, Ondo, Anambra Cross River, Kwara, Borno, Taraba, Oyo, Imo, Kano, Katsina, Gombe, Niger Ogun, Kogi, Bauchi, Akwa Ibom and Abia.

Meanwhile, eight persons have so far tested positive for monkeypox in Edo state, and all the people diagnosed with the disease have recovered.

The Director, Public Health, Edo State Ministry of Health, Dr Ojeifo Stephenson, said it has become imperative to warn the residents of the state about the health risks that the virus poses and reiterate the need to be cautious and adhere to preventive measures.

He said the state Ministry of Health with support from the World Health Organization (WHO) and partners, has ramped up surveillance, diagnostics and other activities to curb the spread of infectious diseases.

“We have stepped up surveillance including prompt investigation of suspected cases, facilitating documentation of contacts, contact tracing and monitoring, as well as developed and disseminated public health advisory to raise awareness about the disease among residents of the state,” he said.

Additionally, Dr Benson Okwara, who works at UBTH, said WHO has been an invaluable partner in the response to monkeypox diagnosis and treatment in the facility.

Dr Okwara has five years of experience in managing patients with monkeypox.

He lamented that the disease spreads within the communities because of the poor health-seeking behaviour and late presentation of the case to the hospital.

“However, with WHO’s coordination, there is an early response following notification of suspected/confirmed cases with detailed case investigations using the monkeypox case investigation form (CIF) to collect data on patient contacts.

“There is a need for continuous risk messaging to educate people about infectious diseases and the importance of seeking medical care early and at appropriate health facilities to prevent the spread of diseases,” he said.

Across Nigeria, the Nigeria Centre for Disease Control (NCDC), supported by WHO, has activated Monkeypox Emergency Operations Centre to strengthen in-country preparedness and contribute to the global response to the outbreak.

Furthermore, WHO is supporting the coordination of technical assistance and operational support of partners, including the national One-health risk surveillance and information sharing (NOHRSIS) group, to facilitate timely information exchange on all prioritized zoonotic diseases.

Monkeypox is a zoonotic disease endemic in Nigeria and some parts of Africa.

However, there has been sporadic spread to other countries as more than 16,000 cases of monkeypox have been reported across more than 70 countries so far this year, and the number of confirmed infections rose 77 per cent from late June through early July.

The virus is being transmitted from animals to humans.

Recently, WHO activated its highest alert level for the growing monkeypox outbreak, declaring the virus a public health emergency of international concern.

Continue Reading

Health

WHO to Help Nigeria Achieve NHIA Act 2022 Objectives

Published

on

world health organization WHO

By Adedapo Adesanya

The World Health Organization (WHO) has expressed its desire to support Nigeria in operationalising the National Health Insurance Authority (NHIA) Act 2022 signed by President Muhammadu Buhari in May 2022.

WHO’s Country Representative (WR), Dr Walter Kazadi Mulombo, made this pledge during a high-level meeting with the Secretary to the Government of the Federation (SGF), Mr Boss Mustapha, the Director General, National Health Insurance Authority (NHIA), Professor Mohammed Sambo, and a team of WHO Health Financing Mission delegates from the WHO Geneva, Africa Regional Office, and Nigeria.

The first ever high-level WHO Health Financing Mission to Nigeria, led by Dr Joseph Kutzin, was scheduled to provide sustainable health financing support to the country towards Universal Health Coverage (UHC) and health security while undertaking targeted advocacy to accelerate operationalization of the NHIA Act including the Vulnerable Group Fund (VGF).

This is in line with WHO’s goal of ensuring that all individuals and communities receive the quality health services they need without suffering financial hardship.

Dr Mulombo said President Buhari’s signing of the NHIA Bill into law will make health insurance mandatory for all legal residents in Nigeria and expands coverage to over 83 million poor and vulnerable people.

He expressed the optimism that government will prioritize immediate appropriation of the Special Intervention Fund in the Act to establish the Vulnerable Group Fund.

“Indeed, the task of ensuring that all citizens have access to the quality healthcare they need without falling into poverty is a deliberate political decision to achieve the cardinal objectives of population coverage, service coverage, and financial protection. I have no doubts that in a large federal nation like Nigeria, this milestone of appropriating the Special Intervention Fund will be achieved in the 2023 fiscal year”, he said.

In his remarks, Mr Mustapha appreciated WHO as the foremost development partner to Nigeria on health and lauded WHO’s invaluable guidance, particularly on the COVID-19 pandemic.

“WHO has demonstrated that it is an organization that cares for and caters for the health needs of the people. On the NHIA, let me commend the DG for his tenacity and determination to have this Act come to fruition. I want to thank WHO and other partners who supported in the drafting of the Bill. This modest attempt has provided basic health insurance coverage to the vulnerable, and making it mandatory will go a long way in assisting our people to manage their income and remain at work in terms of the depressed economy we are witnessing”.

The SGF further expressed the government’s commitment to appropriate the Special Intervention Fund (SIF) in the 2023 national budget for the establishment of the Vulnerable Group Fund (VGF).

“No family in Nigeria has economically survived catering for any of their own suffering from cancer. The health of our people is therefore topmost on our priorities despite competing demands”, he stated.

Continue Reading

Health

Monkeypox: Russians Are Back With Cheap Health Publicity

Published

on

Monkeypox Test cheap health publicity

By Kestér Kenn Klomegâh

With rising cases of the monkeypox virus, Russians are back seeking again cheap health publicity in Africa. Just as Foreign Minister Sergey Lavrov completed his four African-nation tours, Russia plans to send monkeypox test kits to Egypt, Uganda, Ethiopia and Congo.

Russian consumer health watchdog Rospotrebnadzor said in a media statement that Russian test systems to diagnose monkeypox would be provided to Egypt, Uganda, Ethiopia, and the Republic of Congo at the end of July.

“Rospotrebnadzor is continuing to extend support to partner countries’ efforts to counter the spread of monkeypox. Test systems produced by Rospotrebnadzor’s Vector Research Center will be handed over to Egypt, Uganda, Ethiopia, and the Republic of Congo at the end of July,” the press service said.

“Furthermore, Rospotrebnadzor specialists are arranging special workshops for colleagues from partner countries that deal with laboratory methods to diagnose monkeypox,” it said.

Rospotrebnadzor said earlier that the Vector Research Center had produced monkeypox test kits, and such testing is currently available in all Russian regions.

Monkeypox is a rare infectious disease, most common in remote parts of Central and West Africa. Its symptoms include nausea, fever, rash, itch and muscle pain.

On July 12, Rospotrebnadzor announced the first national case of monkeypox: the patient had returned from Portugal. His symptoms were mild and did not endanger the patient’s life. Rospotrebnadzor said that all his contacts had been promptly identified and were under medical monitoring. The threat of spread has been contained.

Faced with a surge in monkeypox cases, the World Health Organization (WHO) has already declared the outbreak of monkeypox as a global health emergency — the highest alarm it sounded. Monkeypox has affected over 15,800 people in 72 countries, according to a tally by the US Centers for Disease Control and Prevention (CDC) published on July 20.

WHO, however, warned against discrimination. “A failure to act will have grave consequences for global health,” Lawrence Gostin, the director of the WHO Collaborating Center on National and Global Health Law, said on Twitter.

Some experts have asked why Russians have not chosen African countries such as Nigeria, or regions such as Central and West Africa where the virus is currently spreading most. But have listed as priority countries that Sergey Lavrov visited on 24-27 July: Egypt, Ethiopia, Uganda and the Republic of the Congo.

Continue Reading

Latest News on Business Post

Like Our Facebook Page

%d bloggers like this: